Meeder Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-19
| Closed | – | – | 2529 |
|
|
2021
Q3 | $0 | Hold |
19
| – | – | ﹤0.01% | 2709 |
|
|
2021
Q2 | $1K | Hold |
19
| – | – | ﹤0.01% | 2436 |
|
|
2021
Q1 | $1K | Hold |
19
| – | – | ﹤0.01% | 2297 |
|
|
2020
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 1785 |
|
|
2020
Q3 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 2085 |
|
|
2020
Q2 | – | Sell |
-40
| Closed | -$2K | – | 2619 |
|
|
2020
Q1 | $2K | Sell |
40
-8
| -17% | -$400 | ﹤0.01% | 2138 |
|
|
2019
Q4 | $4K | Buy |
48
+8
| +20% | +$667 | ﹤0.01% | 1878 |
|
|
2019
Q3 | $2K | Hold |
40
| – | – | ﹤0.01% | 2014 |
|
|
2019
Q2 | $2K | Hold |
40
| – | – | ﹤0.01% | 1902 |
|
|
2019
Q1 | $2K | Sell |
40
-275
| -87% | -$13.8K | ﹤0.01% | 1592 |
|
|
2018
Q4 | $13K | Buy |
+315
| New | +$13K | ﹤0.01% | 1178 |
|
|
2018
Q3 | – | Sell |
-137
| Closed | -$6.19K | – | 1739 |
|
|
2018
Q2 | $6.19K | Sell |
137
-516
| -79% | -$23.3K | ﹤0.01% | 1222 |
|
|
2018
Q1 | $32K | Buy |
653
+556
| +573% | +$27.2K | ﹤0.01% | 773 |
|
|
2017
Q4 | $4K | Buy |
97
+36
| +59% | +$1.49K | ﹤0.01% | 1394 |
|
|
2017
Q3 | $2K | Sell |
61
-144
| -70% | -$4.72K | ﹤0.01% | 1498 |
|
|
2017
Q2 | $6K | Buy |
205
+59
| +40% | +$1.73K | ﹤0.01% | 1159 |
|
|
2017
Q1 | $5K | Sell |
146
-490
| -77% | -$16.8K | ﹤0.01% | 1112 |
|
|
2016
Q4 | $9K | Buy |
+636
| New | +$9K | ﹤0.01% | 779 |
|